What is cardiac surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Cardiac Surgery?

Cardiac surgery is a specialized surgical field that involves invasive procedures on the heart and great vessels to treat severe coronary, valvular, or myocardial disease, providing definitive therapy for patients with these conditions. 1

Types of Cardiac Surgical Procedures

  • Coronary Artery Bypass Grafting (CABG): A procedure that provides mortality benefit in defined populations by restoring blood flow to the heart muscle. More than 300,000 patients undergo CABG annually in the United States, with approximately 50% of these patients being older than 65 years with multiple comorbidities. 1

  • Valve Surgery: Procedures to repair or replace damaged heart valves (mitral, aortic, tricuspid, pulmonary) that have resulted in improved survival and quality of life for patients with end-stage heart disease from obstructed or leaking native heart valves. 1

  • Heart Transplantation: Once considered experimental, heart transplantation has now been established as standard care for end-stage heart failure. 1

  • Mechanical Circulatory Support: Implementation of complex implantable pumps that provide effective short-term treatment for the failing heart, with long-term mechanical support for severe heart failure becoming increasingly feasible. 1

  • Pediatric Heart Surgery: Significant advances have been made in this field, including lifesaving procedures such as definitive repair of hypoplastic left heart syndrome. 1

Evolution and Technological Advances

  • Cardiopulmonary Bypass: The introduction of the heart-lung machine enabled direct surgery on the heart by maintaining circulation while the heart is stopped. 2

  • Minimally Invasive Techniques: New developments include:

    • Off-pump CABG (OPCAB) performed on the beating heart 1
    • Robotic and endoscopic approaches that offer alternatives to standard open chest surgery 1, 3
    • New anastomotic devices that facilitate partial and total endoscopic CABG techniques 3
  • Biotechnology and Cell-Based Therapy: Emerging approaches include:

    • Pluripotent stem cell or myoblast implants 1
    • Tissue engineering for heart valves, vascular conduits, and muscle patches 1
    • Therapeutic angiogenesis using angiogenic factors 4

Outcomes and Quality Measures

  • Mortality and Morbidity: Despite advances, cardiac surgical procedures remain among the most invasive and expensive therapeutic techniques in modern medicine, with significant risks. 1

  • Quality of Life: Enhanced postoperative quality of life and functional capacity are key indicators of surgical success following cardiac procedures. 5

  • Cardiac Rehabilitation: This plays a pivotal role in enhancing patient function, reducing frailty, and improving long-term quality of life after cardiac surgery. 5

Challenges and Future Directions

  • Aging Population: An increasing percentage of cardiac surgery patients are older with multiple comorbidities related to generalized atherosclerosis. 1

  • Novel Cardioprotective Strategies: Approaches such as remote ischemic conditioning and pharmacological interventions are being developed to reduce perioperative myocardial injury. 4

  • Implementation of New Technologies: Novel imaging technologies and training methods will be necessary for implementing advanced minimally invasive cardiac surgical techniques. 4

  • Financial Constraints: The major drawback for the achievement of this amazing progress is the financial cost, requiring an open debate between all parties concerned in healthcare. 3

Common Pitfalls and Caveats

  • Patient Selection: The indications for coronary intervention should not be redefined simply because a patient requires a major noncardiac procedure. The long-term implications of severe coronary disease remain significant regardless of other surgical needs. 1

  • Perioperative Risk Assessment: Cardiovascular morbidity and mortality vary not only among procedures but also among institutions for the same procedure, requiring individualized risk assessment. 1

  • Translating Experimental Findings: Multiple cardioprotective therapies that showed promise in laboratory settings have failed to demonstrate benefits in clinical trials, highlighting the need for rigorous clinical testing. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cardiac surgery: a century of progress.

Texas Heart Institute journal, 2011

Research

New developments in cardiac surgery.

Acta cardiologica, 2004

Guideline

Cardioprotective Strategies and Pharmacological Approaches

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.